Genetic vs immune strategies in breast cancer
Genetic vs immune strategies in breast cancer
Transforming patient care through translational research
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity
GTX-024 for androgen receptor positive breast cancer
Adaptive trial design on breast cancer
Identifying cancer in dense breast tissue
Editor's Choice for April 2017
Discovering genes in mammary cancer by insertional mutagenesis
Long-term clinical outcomes and analyses of atezolizumab for mTNBC
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses